Dysport phase III study results in children with cerebral palsy

Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the scientific journal Pediatrics published the detailed results of the phase III randomized study (NCT01249417) showing both the efficacy and the safety of Dysport® in the treatment of  dynamic equinus foot deformity (also known as pediatric lower limb spasticity), a condition associated with cerebral palsy in children.

See the full article here:

https://www.news-medical.net/news/20160128/Dysport-phase-III-study-results-in-children-with-cerebral-palsy-with-lower-limb-spasticity-published-in-Pediatrics.aspx

Leave a Reply